KEYNOTE-905/EV-303 Trial: Perioperative Enfortumab Vedotin and Pembrolizumab in Muscle-Invasive Bladder Cancer
Donjeta Bali: United, We Make Every Child’s Victory Possible
Call for Papers: Special Series on Cancer in the Middle East in 2026
Cherie Myatt Steps Into Interim President Role at Vaniam Group
Todd Harper: Cancer Research Giving Day Raised $671,000 Towards Cancer Research
Cancer Patients Invited to Share Their Experiences in Conversations About Surgery
KEYNOTE-091 (PEARLS): Adjuvant Pembrolizumab in Resected NSCLC
Hope 4 Kids Albania: Committed to Ensuring Access to Care for Every Child Fighting Cancer
The ESMO Asia Congress 2026 is the premier scientific platform in the Asia-Pacific region for oncology professionals, scheduled for December 4-6, 2026, in Singapore. Organized by the European Society for Medical Oncology (ESMO), this major international congress brings together global experts and regional leaders to present the latest research and clinical data across all major […]
